Autonomous Orthopedics: The Force-Domain Platform for Physical AI in Orthopedic Surgery
Kambiz Behzadi
July 7, 2026
ESSOB - Electronic Signature Sizing of Bone:
Characterizes the mechanical signature of bone preparation and implant interaction.
To medtech leadership, big tech physical-AI teams, and professors working in control, AI, robotics, biomechanics, and surgical systems:
The next frontier in orthopedic robotics is not only spatial accuracy. It is force control.
During the last decade, orthopedic robotics has focused heavily on the spatial layer: alignment, resection boundaries, implant position, drill trajectories, navigation, and preoperative planning. That layer matters. But it is not enough. The hardest remaining problems in many orthopedic procedures occur at the bone-tool and bone-implant interface, where living bone is contacted, cut, broached, reamed, vibrated, impacted, seated, compressed, and fixed.
Bone is patient-specific, anisotropic, heterogeneous, viscoelastic, fracture-limited, and mechanically unpredictable at the local level. A prosthesis can be positioned correctly and still be mechanically unstable.
A broach can follow the plan and still create unsafe hoop stress. An implant can look aligned and still be under-seated, over-impacted, or installed through a force history that increases fracture risk. These are not primarily vision problems. They are contact mechanics, sensing, estimation, and control problems.
That is the opportunity for Autonomous Orthopedics (AO).
AO is a platform field: closed-loop force-domain orthopedics. It is not merely adding sensors to existing instruments. Sensors alone produce data. A platform integrates sensorized electromechanical tools, bone-specific signal characterization, adaptive force, energy, displacement, and temporal control, vibration-assisted insertion, robotic execution, physics-informed AI, patient-specific biomechanical modeling, and distributed learning across cases.
MedTech leaders should care because the next defensible layer in orthopedics may not be another implant geometry, tray, camera, or navigation map. It may be the force layer: the architecture that controls how implants physically engage bone. Whoever owns that layer may own the data, control laws, mechanical
outcome models, instrumentation pathway, and future standard of care for fixation.
Big Tech leaders should care because physical AI needs high-value arenas where models do not merely generate language or classify images, but sense the physical world, estimate hidden state, predict failure, and act under safety constraints. Orthopedics is an unusually clean arena for this transition. It is mechanical, high-volume, high-cost when failure occurs, procedure-structured, simulation-compatible, and outcome- measurable. The operating room and the orthopedic laboratory can become real-world testbeds for embodied AI: contact-rich, safety-bounded, economically meaningful, and medically consequential.
University professors in control, AI, robotics, biomechanics, and surgical engineering should care because AO is a rich frontier problem. The plant is not a fixed machine; it is living bone. The state is partially observable. The failure boundaries are patient-specific. The system is nonlinear, contact-rich, and uncertain.
The control problem involves force, displacement, energy, vibration, impedance, stiffness, fracture risk, seating state, and tissue response. This is fertile ground for model predictive control, adaptive control, hybrid systems, Bayesian state estimation, digital twins, safe reinforcement learning, sim-to-real transfer, haptics, robot-assisted intervention, and physics-informed machine learning.
The AO architecture includes four related technical pillars:
Together, these are not simply product features. They define a new control layer for orthopedic surgery.
The strategic question is direct: who will own the force-domain architecture of orthopedic robotics?
- Who will own bone-tool and bone-implant interface data?
- Who will own intraoperative mechanical signatures of bone?
- Who will own the predictive models that estimate seating, stability, fracture risk, and local bone response?
- Who will own adaptive force-control policies that decide when to advance, pause, vibrate, redirect, reduce energy, terminate impaction, or continue seating?
- Who will own the robotic execution layer that converts prediction into safe physical action?
- Who will own the distributed learning system that improves across implants, procedures, bone types, surgeons, hospitals, and institutions
This is a strategic race because the force layer is closer to the outcome than the spatial layer alone. Alignment matters, but fixation mechanics determine whether the implant actually integrates, seats, stabilizes, and survives.
For investors and strategic partners, AO creates several possible value streams: proprietary intraoperative mechanical datasets, implant-agnostic instrumentation, force-aware robotic workflows, AI-enabled planning and execution, adaptive control IP, clinical decision support, training and standardization tools, and a physical-AI platform in a large orthopedic market. For academic groups, it creates a translational research field where theory can be tested against measurable physical interaction. For MedTech, it creates a route to differentiated outcomes. For Big Tech, it creates a medically significant arena for embodied intelligence.
The ambition is simple and consequential: transform elite surgical feel into reproducible engineering.
Today, much of implant surgery still depends on qualitative feel: the resistance of bone, the changing sound of impaction, the tactile sense of seating, and the surgeon’s judgment that one more strike is safe – or that it is one strike too many. Expert surgeons develop this judgment over thousands of cases. The system should help make that skill measurable, teachable, reproducible, and safer.
The path forward is not to remove the surgeon. It is to augment the surgeon with a closed-loop force-domain system that senses, models, predicts, and controls the mechanical interaction between instrument, implant, and bone.
That is why AO should matter to MedTech: it can become the operating system for force-aware orthopedics.
That is why AO should matter to Big Tech: it can become a real-world medical arena for physical AI.
That is why AO should matter to universities: it can become a frontier research platform for control, robotics, AI, biomechanics, and surgical autonomy.
Orthopedic robotics began by controlling where instruments and implants go.
The next platform will control how force enters bone.
Whoever controls the force layer will be positioned to control the outcome layer.
Index: Terms, Platform Roles, and Patent References
| Term | Platform Role | Patent/application references |
|---|---|---|
| AO – Autonomous Orthopedics | Closed-loop force-domain robotics platform for orthopedic surgery. | US Provisional 63/756,278 (Feb. 10, 2025); US Provisional 63/765,699 (Mar. 2, 2025); US Utility 19/533,256 (Feb. 8, 2026); CIP 19/686,743 (May 24, 2026); CIP 19/701,137 (June 8, 2026). |
| ESSOB – Electronic Signature Sizing of Bone | Sensorized electromechanical characterization of bone preparation and implant interaction. | US 12,599,455 (issued); US Provisional 63/481,126; US Provisional 63/528,591. |
| APIM – Automatic Prosthesis Installation Machine | Adaptive force-control system for controlled force, energy, displacement, and temporal delivery during prosthesis installation and fixation. | US 11,331,069; US 11,298,102; US 11,291,426; US 11,202,668; US 11,191,517; US 11,109,802; US 10,912,655; US 10,849,766; US 10,441,244. |
| VIOI – Vibratory Insertion of Orthopedic Implants | Adaptive force-control and vibration-assisted insertion system for modifying the bone-implant interface and reducing unsafe peak forces. | US 11,576,790; US 11,234,840; US 10,729,559; US 10,610,379; US 10,478,318; US 10,413,425; US 10,245,160; US 10,172,722; US 9,168,154; EP 3,089,685. |
| BONES – Biomechanical Optimized Neural Engineering System | Physics-informed AI and biomechanical modeling layer that converts intraoperative mechanical data into patient-specific predictive control logic. | No separate patent application. BONES is part of the AO platform applications. |
| Physical AI | Embodied artificial intelligence that senses, models, predicts, and controls physical interaction with the real world. | Implemented in the AO architecture through sensing, modeling, adaptive control, robotic execution, and distributed learning. |
Patents and Applications Related to AO, ESSOB, APIM, and VIOI
| Portfolio area | Patent/application numbers |
|---|---|
| AO – Autonomous Orthopedics | US Provisional 63/756,278 – filed Feb. 10, 2025 US Provisional 63/765,699 – filed Mar. 2, 2025 US Utility 19/533,256 – first conversion of AO provisionals, filed Feb. 8, 2026 CIP 19/686,743 – filed May 24, 2026 CIP 19/701,137 – filed June 8, 2026 |
| ESSOB – Electronic Signature Sizing of Bone | US 12,599,455 – issued patent US Provisional 63/481,126 US Provisional 63/528,591 |
| APIM – Automatic Prosthesis Installation Machine / Adaptive Force Control | US 11,331,069 US 11,298,102 US 11,291,426 US 11,202,668 US 11,191,517 US 11,109,802 US 10,912,655 US 10,849,766 US 10,441,244 |
| VIOI – Vibratory Insertion of Orthopedic Implants / Adaptive Force Control | US 11,576,790 US 11,234,840 US 10,729,559 US 10,610,379 US 10,478,318 US 10,413,425 US 10,245,160 US 10,172,722 US 9,168,154 EP 3,089,685 |
| BONES | No independent application listed. BONES is described as part of AO |
Note: Patent and application references are included for strategic communication and should be confirmed by patent counsel before formal publication, financing materials, or diligence use.